ABIVAX (EPA:ABVX) | WebDisclosure

PRESS RELEASE

published on 07/15/2024 at 22:00, 4 months 8 days ago

Abivax fournit une mise à jour opérationnelle et fait le point sur son programme clinique clé
Abivax fournit une mise à jour opérationnelle sur son programme clinique ABTECT pour la rectocolite hémorragique, l'essai d'induction de 8 semaines et les nouvelles nominations au sein de l'équipe dirigeante

Abivax Nominations Rectocolite Hémorragique Mise À Jour Opérationnelle Programme Clinique
PRESS RELEASE

published on 07/15/2024 at 22:00, 4 months 8 days ago

Abivax Provides Operational and Key Program Update
Abivax provides operational and key program update, including progress on clinical trials, leadership changes, and financial update

Leadership Changes Abivax Clinical Trials Operational Update Financial Update
PRESS RELEASE

published on 07/15/2024 at 22:00, 4 months 8 days ago

Abivax fournit une mise à jour opérationnelle et fait le point sur son programme clinique clé
Abivax fournit une mise à jour sur son programme clinique clé, incluant des avancées significatives dans l'essai de phase 3 ABTECT évaluant Obefazimod pour la rectocolite hémorragique modérément à sévère

Abivax Obefazimod Rectocolite Hémorragique Mise À Jour Programme Clinique
BRIEF

published on 06/28/2024 at 18:05, 4 months 25 days ago

ABIVAX: Summary of the Number of Shares and Voting Rights as of May 31, 2024

Voting Rights Actions AMF Abivax Transparency
BRIEF

published on 06/28/2024 at 18:05, 4 months 25 days ago

ABIVAX: Bilan du Nombre d'Actions et de Droits de Vote au 31 Mai 2024

Droits De Vote Actions AMF Abivax Transparence
PRESS RELEASE

published on 06/28/2024 at 18:00, 4 months 25 days ago

ABIVAX: Nombre d’actions composant le capital social et nombre total de droits de vote au 31.05.24
ABIVAX annonce le nombre d'actions et de droits de vote au 31 mai 2024 conformément aux exigences réglementaires. La société de biotechnologie se concentre sur le développement de traitements pour les maladies inflammatoires chroniques

Droits De Vote Biotechnologie Actions Abivax Maladies Inflammatoires
BRIEF

published on 05/29/2024 at 18:05, 5 months 25 days ago

ABIVAX: Nombre d’actions et droits de vote au 30 avril 2024

Droits De Vote Actions AMF Abivax Réglementaire
BRIEF

published on 05/29/2024 at 18:05, 5 months 25 days ago

ABIVAX: Number of shares and voting rights as of April 30, 2024

Voting Rights Actions AMF Abivax Regulatory
PRESS RELEASE

published on 05/29/2024 at 18:00, 5 months 25 days ago

ABIVAX: Nombre d’actions composant le capital social et nombre total de droits de vote au 30.04.24.
ABIVAX communique le nombre d'actions et de droits de vote au 30.04.24 conformément aux règlements de l'AMF et du Code de commerce

Droits De Vote Capital Social Code De Commerce Abivax Règlement AMF
BRIEF

published on 05/08/2024 at 08:35, 6 months 15 days ago

Presentation of Obefazimod for Ulcerative Colitis and Colon Cancer at DDW 2024

Abivax Obefazimod Ulcerative Colitis Digestive Disease Week Colon Cancer

Published on 11/22/2024 at 23:55, 1 day 1 hour ago

Boron One Announces Early Warrant Exercise Incentive Program
Published on 11/22/2024 at 23:30, 1 day 2 hours ago

Electric Royalties Enters Into Definitive Agreement to Acquire 0.75% Gross Revenue Royalty on Producing Punitaqui Copper Mine in Chile
Published on 11/22/2024 at 23:05, 1 day 2 hours ago

Kidoz Inc. Announces Results of 2024 AGM
Published on 11/22/2024 at 23:05, 1 day 2 hours ago

Nexa Resources Announces Closing Transaction of Pukaqaqa Project Sale to Olympic
Published on 11/22/2024 at 22:30, 1 day 3 hours ago

Delaforce Energy Corp. Announces Acquisition of Bouchard Well Service Ltd.

View all ACCESSWIRE

Published on 11/22/2024 at 18:14, 1 day 7 hours ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/22/2024 at 18:00, 1 day 7 hours ago

Holding(s) in Company
Published on 11/22/2024 at 17:53, 1 day 7 hours ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/22/2024 at 16:55, 1 day 8 hours ago

EQS-Adhoc: Comment on withdrawn non-binding offer
Published on 11/22/2024 at 16:00, 1 day 9 hours ago

Proposed cancellation of admission to trading

View all EQS

Published on 11/22/2024 at 17:45, 1 day 8 hours ago

IMMERSION : RFA 2023/2024
Published on 11/22/2024 at 16:15, 1 day 9 hours ago

NRJ GROUP - Le Conseil d'Etat rejette le recours de NRJ 12 et NRJ GROUP
Published on 11/22/2024 at 14:35, 1 day 11 hours ago

Communiqué de presse Thales
Published on 11/22/2024 at 14:35, 1 day 11 hours ago

Thales Press release
Published on 11/21/2024 at 06:58, 2 days 18 hours ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio

View all LES ECHOS COMFI WIRE

News